Professor Hisham Mehanna
PhD, BMedSc (hons), MB ChB (hons), FRCS, FRCS (ORL-HNS)
Chair of Head and Neck Surgery, Director of the Institute of Head and Neck Studies and Education, University of Birmingham, UK
Hisham’s clinical interests are recurrence head and neck cancer surgery, paraganglioma, thyroid and minimal access parathyroid surgery. Hisham has a keen interest in clinical and translational research, heading a research team of 20 researchers, and holding over £12 million in research grants. The main areas of his research are Human Papillomavirus-associated HNC and thyroid cancer. His research themes are biomarkers of treatment response and early and late phase clinical trials in HNC. He is chief investigator of several multicentre and multinational clinical trials, including the PET NECK trial, (NEJM in 2016) and De-ESCALaTE (Lancet 2018).
He is the current President of the British Association of Head Neck Oncologists (BAHNO), the UK’s multi-disciplinary professional body. He is also the Past Chair of the UK's National Cancer Research Institute’s head and neck group, responsible for all HNC research in the UK. He is also the Secretary of the Head and Neck International Group, a collaboration of 20 national clinical trials groups.
Hisham did his senior clinical fellowship at the Auckland City Hospital Head and Neck Unit in 2004.